Cargando…
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer
BACKGROUND: A number of protein markers have been investigated as prognostic adjuncts in breast cancer but their translation into clinical practice has been impeded by a lack of appropriate validation. Recently, we showed that BCL2 protein expression had prognostic power independent of current used...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430210/ https://www.ncbi.nlm.nih.gov/pubmed/18510726 http://dx.doi.org/10.1186/1471-2407-8-153 |